Amgen's Otezla Receives Expanded FDA Approval for Plaque Psoriasis
Amgen Inc.'s treatment Otezla was approved by the U.S. Food and Drug Administration to treat adults with all levels of plaque psoriasis.
More from California Business
North California Record
Following state appellate ruling involving ADA claims, further relief urged at federal level
California Business
•
Dec 5, 2022
FresnoBee | Business
Here's How to Keep Winter Utility Bills Down as Energy Costs Rise
California Business
•
Dec 5, 2022
East Bay Times | Business
Released Twitter emails show how employees debated how to handle 2020 New York Post Hunter Biden story
California Business
•
Dec 5, 2022